The significance of Brf1 overexpression in human hepatocellular carcinoma

Qian Zhong; Shaoyan Xi; Jianzhong Liang; Ganggang Shi; Yi Huang; Yanmei Zhang; Daniel Levy; Shuping Zhong

doi:10.18632/oncotarget.6668

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

The significance of Brf1 overexpression in human hepatocellular carcinoma

Qian Zhong, Shaoyan Xi, Jianzhong Liang, Ganggang Shi, Yi Huang, Yanmei Zhang, Daniel Levy and Shuping Zhong _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:6243-6254. https://doi.org/10.18632/oncotarget.6668

Metrics: PDF 1730 views | HTML 2232 views | ?

Abstract

Qian Zhong1,*, Shaoyan Xi1,*, Jianzhong Liang1,*, Ganggang Shi2, Yi Huang3, Yanmei Zhang2,3, Daniel Levy3, Shuping Zhong2,3

1State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China

2Shantou University Medical College, Shantou, Guangdong, China

3Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

*These authors have contributed equally to this work

Correspondence to:

Shuping Zhong, e-mail: [email protected]

Keywords: Brf1, Pol III genes, hepatocellular carcinoma, survival, alcohol

Received: September 08, 2015 Accepted: December 07, 2015 Published: December 18, 2015

ABSTRACT

Brf1 (TFIIB-related factor 1) plays a crucial role in cell transformation and tumorigenesis. However, the significance of Brf1 expression in human HCC (hepatocellular carcinoma) cases remains to be addressed. In this study, biopsies of human HCC, liver tumor samples of mice and cell lines of normal and tumor liver were utilized to determine the alteration of Brf1 expression using cytological and molecular biological approaches. Brf1 expression is increased in human HCC cases, which is correlated with shorter survival times. Levels of Brf1 and Pol III (RNA polymerase III-dependent) gene transcription in HCC patients with alcohol consumption are higher than the cases of non-HCC with or without alcohol intake. Induction of Brf1 and Pol III genes by ethanol in hepatoma cells is higher than in non-tumor cells. Ethanol increases the rate of cell transformation. Repression of Brf1 inhibits alcohol-promoted cell transformation. Alcohol consumption enhances Brf1 expression to promote cell transformation. These studies demonstrate that Brf1 is a new biomarker of HCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6668

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

The significance of Brf1 overexpression in human hepatocellular carcinoma

Abstract